Etid klinik pou BPCO nan Texas
25 etid pou BPCO ap chèche patisipan nan sit nan Texas.
Vil nan Texas
- Houston15 etid
- Dallas12 etid
- El Paso5 etid
- McKinney5 etid
- Cypress4 etid
- Mesquite4 etid
- Grand Prairie3 etid
- Sugar Land3 etid
- Lewisville3 etid
- Denison3 etid
- The Woodlands3 etid
- San Antonio3 etid
Tèks ofisyèl etid la (Anglè)
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Horizon Clinical Research Group., Cypress
- Metroplex Pulmonary and Sleep Center, McKinney
- DM Clinical Research- Tomball, Tomball
Ap rekriteFaz 2
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50001, Boerne
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
Ap rekriteFaz 2
Laj 40 a 75 · Tout sèks · Mizajou Sep 25, 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont
Ap rekriteFaz 4
Laj 40 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Wellness Clinical Research - Allen- Site Number : 8400085, Allen
- REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
- Novel Research - Bellaire- Site Number : 8400116, Bellaire
- ak 17 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- University of Texas Southwestern, Dallas
Ap rekrite
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, McKinney
- WB Contracted Clinical Research Site, Waxahachie
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07646587Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- IntraCare- Site Number : 8400034, Dallas
- Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
- El Paso Pulmonary Association- Site Number : 8400033, El Paso
- ak 5 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Boerne
- Research Site, Dallas
- Research Site, Denison
- ak 5 plis
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Dallas
- Research Site, Forney
- Research Site, Fort Worth
- ak 5 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Boerne
- Research Site, El Paso
- Research Site, Houston
- ak 6 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- The Lung & Sleep Institute of North Texas, North Richland Hills
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Ten20 Clinical Research, Carrollton
- Horizon Clinical Research Group, Cypress
- ak 4 plis
Ap rekriteFaz 2/3
Laj 35 a 80 · Tout sèks · Mizajou Aug 31, 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Abilene
- Research Site, Brownsville
- Research Site, Dallas
- ak 12 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Aug 26, 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Aug 11, 2026 · NCT07555483STRIVE Post-Market Registry Study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
- University of Texas Health Science Center at Houston, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Dallas
- GSK Investigational Site, DeSoto
- GSK Investigational Site, Greenville
- ak 6 plis
Ap rekriteFaz 3
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05181826Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Houston Methodist/Primary Critical Care, Houston
Ap rekrite
Laj 40 a 84 · Tout sèks · Mizajou Apr 24, 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, El Paso
- ak 5 plis
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Corsicana
Ap rekriteFaz 3
Laj 40 a 80 · Tout sèks · Mizajou Oct 8, 2025 · NCT06959095Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Texas A&M Family Care, Bryan
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 12, 2025 · NCT06726590Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
Ap rekriteEtid obsèvasyon
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Respire Research Institute, Houston
Ap rekrite
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.